Suppr超能文献

对伴有难以控制腹水的肝细胞癌患者进行单次质子照射。技术考量与结果。

Proton irradiation in a single fraction for hepatocellular carcinoma patients with uncontrollable ascites. Technical considerations and results.

作者信息

Hata Masaharu, Tokuuye Koichi, Sugahara Shinji, Tohno Eriko, Fukumitsu Nobuyoshi, Hashimoto Takayuki, Ohnishi Kayoko, Nemoto Keiko, Ohara Kiyoshi, Sakae Takeji, Akine Yasuyuki

机构信息

Proton Medical Research Center, University of Tsukuba, Tsukuba, Ibaraki, Japan.

出版信息

Strahlenther Onkol. 2007 Aug;183(8):411-6. doi: 10.1007/s00066-007-1640-2.

Abstract

PURPOSE

To present technical considerations and results of proton irradiation in a single fraction for hepatocellular carcinoma (HCC) patients with uncontrollable ascites.

PATIENTS AND METHODS

Three HCC patients with uncontrollable ascites underwent proton irradiation of 24 Gy in a single fraction. Hepatic tumors were solitary in two patients, and multiple in one, and tumor sizes were 30, 30, and 33 mm in maximum diameter. No patient had lymph node or distant metastases. The center position of radiation fields was determined and the beam range was adjusted, using CT data taken immediately before irradiation to compensate for changes in the volume of ascites. Adjustment of the beam range was within 6 mm in water-equivalent thickness.

RESULTS

All irradiated tumors showed objective responses, and were controlled during the follow-up period. Of the three patients, two were alive with no evidence of disease at 13 and 30 months, respectively, after treatment. The remaining patient died of ruptured esophageal varices 6 months after treatment. No therapy-related toxicity of grade 3 or more was observed.

CONCLUSION

Proton beams were successfully adjusted immediately before irradiation. Single-dose irradiation with precisely adjusted proton beams may be tolerable for HCC patients with uncontrollable ascites.

摘要

目的

介绍对伴有无法控制腹水的肝细胞癌(HCC)患者进行单次质子照射的技术要点及结果。

患者与方法

3例伴有无法控制腹水的HCC患者接受了单次24 Gy的质子照射。2例患者的肝肿瘤为单发,1例为多发,最大直径分别为30、30和33 mm。所有患者均无淋巴结或远处转移。利用照射前即刻获取的CT数据确定辐射野的中心位置并调整射束范围,以补偿腹水体积的变化。射束范围的调整在水等效厚度6 mm以内。

结果

所有接受照射的肿瘤均显示出客观反应,并在随访期间得到控制。3例患者中,2例分别在治疗后13个月和30个月时存活且无疾病证据。其余1例患者在治疗后6个月死于食管静脉曲张破裂。未观察到3级或以上的治疗相关毒性反应。

结论

在照射前成功地对质子束进行了调整。精确调整的质子束单次照射对于伴有无法控制腹水的HCC患者可能是可耐受的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验